Diltiazem

Diltiazem is a prescription medication classified as a calcium channel blocker, commonly used to treat high blood pressure (hypertension), angina (chest pain), and certain heart rhythm disorders.

By relaxing blood vessels and slowing electrical conduction through the heart, diltiazem improves blood flow, lowers blood pressure, and helps control heart rate. These effects reduce cardiac strain and help prevent complications, such as heart attacks and worsening arrhythmias.

Diltiazem is well absorbed from the gastrointestinal tract and undergoes first-pass hepatic metabolism. It is available in both immediate-release and extended-release formulations, allowing clinicians to tailor dosing schedules to individual cardiovascular needs.

Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.

What Is Cardizem?

Cardizem is the brand-name formulation of diltiazem and contains the same active ingredient as the generic versions. It is prescribed for the same cardiovascular indications, including hypertension, angina, and certain arrhythmias.

Cardizem is available in specific immediate-release and extended-release formulations designed to provide consistent blood levels and predictable control of heart rate and blood pressure.

While Cardizem and generic diltiazem are therapeutically equivalent, patients should remain on the specific formulation prescribed, as switching between different release types can affect symptom control.

• Critical 2025 Update: Cardiologists stress the importance of distinguishing non-DHP calcium channel blockers, such as Cardizem (diltiazem), from DHP agents, such as Norvasc (amlodipine). Because Cardizem directly slows conduction through the heart’s AV node, it can worsen heart block or heart failure with reduced ejection fraction. Current guidelines recommend confirming cardiac safety with an EKG and/or echocardiogram before starting therapy to ensure the heart’s electrical system can tolerate its rate-slowing effects.

Cardizem is a calcium channel blocker prescribed to manage several cardiovascular conditions that affect heart function and blood pressure. By relaxing cardiac and vascular muscle, Cardizem improves blood flow, reduces cardiac workload, and stabilizes the heart rhythm in specific clinical scenarios.

Primary Indications

Cardizem is primarily indicated for the following conditions:

• Hypertension (High Blood Pressure): Cardizem lowers blood pressure by relaxing vascular smooth muscle, thereby reducing cardiac workload. This lowering of blood pressure helps minimize the long-term risk of serious cardiovascular events such as heart attack and stroke.
• Angina Pectoris (Chest Pain): By dilating coronary arteries and improving oxygen delivery to the heart muscle, Cardizem alleviates chest pain associated with both stable and variant angina. Its ability to reduce myocardial oxygen demand makes it especially helpful for preventing angina episodes.
• Supraventricular Arrhythmias: Cardizem is effective in controlling heart rate in conditions such as supraventricular tachycardia (SVT) and atrial fibrillation. It slows conduction through the AV node, thereby helping restore a more regular heart rhythm and reducing symptoms such as palpitations or dizziness.
  • Rate Control with Cardizem (2025 Update): Cardizem is considered a gold-standard option for atrial fibrillation rate control, especially in patients with asthma or COPD, because it does not cause bronchial constriction like some beta-blockers. Current guidance also encourages the use of wearable heart monitors (e.g., Apple Watch or Fitbit) to track resting heart rate, with immediate dose adjustment recommended if the rate persists above 110 bpm or falls below 50 bpm to prevent tachy-brady syndrome.

Off-Label Uses

Although not approved by the FDA for these purposes, Cardizem may also be prescribed off-label in certain medical contexts, including:

• Migraine Prophylaxis: Some clinicians use Cardizem’s vasodilatory properties to help reduce migraine frequency or severity. While evidence is limited compared to first-line migraine therapies, select patients may benefit under specialist guidance.
• Heart Failure (Specific Cases Only): In carefully chosen patients, Cardizem may help reduce symptoms by improving cardiac efficiency and reducing afterload. This use requires cautious clinical judgment, as calcium channel blockers are not universally appropriate for all forms of heart failure.

Off-label prescribing is based on clinical experience, patient-specific considerations, and close medical supervision. Decisions to use Cardizem outside of approved indications should always be made collaboratively between healthcare providers and patients.

The mechanism behind Cardizem’s efficacy lies in its ability to block calcium ions from entering the vascular smooth muscle and myocardial cells. 

Mechanism of Action

By inhibiting calcium currents, Cardizem reduces the strength of heart muscle contractions, relaxing blood vessels. This lowers blood pressure and eases the workload on the heart, which can benefit patients with hypertension and angina. Regulation of calcium flow also helps control heart rate, which is particularly useful in treating arrhythmias.

Cardizem’s action as a calcium channel blocker prevents calcium-induced vascular contraction, thereby promoting vasodilation. This opens up the arteries, reduces peripheral resistance, and enhances the delivery of oxygen-rich blood to the heart muscle. Together, these effects help prevent the chest pain associated with angina and stabilize heart rhythms.

Pharmacokinetics

Understanding Cardizem’s pharmacokinetic profile can help healthcare providers fine-tune dosages and monitor patient responses, thereby achieving optimal therapeutic outcomes.

Cardizem is extensively metabolized in the liver, where it undergoes first-pass metabolism, decreasing its bioavailability to 30–40%. That’s still sufficient to exert a therapeutic effect, particularly in the maintenance treatment of chronic conditions. 

The extended-release (ER) forms of Cardizem are designed to provide steady plasma concentrations for once-daily dosing that remains effective for 24 hours. This is critical for conditions requiring consistent blood pressure control and heart rate management.

Excretion of Cardizem’s metabolic by-products happens primarily through urine and feces. The metabolism of Cardizem requires careful consideration in patients with hepatic impairment, as hepatic function is required for its processing.

The dosage and administration of Cardizem depend on the individual patient and condition being treated, and should be determined by a licensed medical provider.

Dosage Recommendations

For hypertension, the typical starting dose of Cardizem is around 180 mg once daily, with adjustments made based on patient response and tolerance.

In angina management, the dosage may range up to 360 mg per day, administered as divided doses or once daily with extended-release products. 

For arrhythmias, the dosage may be adjusted to stabilize heart rate more aggressively, necessitating precise dosing by a healthcare professional.

In pediatric use or less common off-label treatments, dosing must also be delicately balanced and personalized. Dosage adjustments are often necessary to accommodate patient-specific factors such as age, body weight, and concurrent medical conditions.

• 2025 Dosing Clarification: For angina pectoris, diltiazem is now dosed at 120–360 mg per day; for hypertension, at 120–480 mg per day, which may be given once daily or in divided doses, depending on the formulation. Extended-release products are typically taken once daily, while immediate-release forms often require multiple doses per day. Always follow the specific instructions for your prescribed formulation to ensure consistent control of heart rate and blood pressure.

Administration Guidelines

Generally, it is advised to take Cardizem on an empty stomach, as food can interfere with the drug’s bioavailability. Additionally, maintaining a consistent dosing schedule is crucial for effective management of blood pressure and heart rate.

Extended-release forms, indicated by suffixes such as CD, LA, or ER, should be swallowed whole and not crushed or chewed to preserve their controlled-release mechanism.

Patients on Cardizem should closely follow their healthcare provider’s instructions, monitor for changes in symptoms or side effects, and report them promptly. Regular follow-up appointments and blood tests may be necessary to ensure that the medication is effective and does not cause adverse effects.

Cardizem is generally well tolerated; however, like all cardiovascular medications, it can cause a range of side effects. These may be mild and self-limiting or, in some cases, clinically significant. Understanding potential reactions helps patients and healthcare providers monitor safety and adjust treatment when needed.

Common Side Effects

Common side effects of Cardizem include:

• Dizziness and Headache: These symptoms often occur as the body adjusts to changes in blood pressure. They are typically mild but should be monitored if they interfere with daily activities
• Peripheral Edema (Swelling of the Extremities): Swelling of the feet or ankles is a frequent effect of calcium channel blockers like Cardizem. Although usually harmless, persistent edema may require dose adjustments or supportive care.
• Gastrointestinal Discomfort: Nausea, abdominal pain, or mild digestive upset can occur during the early stages of therapy. Taking Cardizem consistently and maintaining adequate hydration may help reduce these effects.
• Gingival Hyperplasia: A less common but important side effect of long-term Cardizem use is gingival hyperplasia (overgrowth of gum tissue). In 2025, it is recommended that patients on Cardizem visit a dentist every 6 months, as strict oral hygiene can prevent this side effect from requiring surgical correction.

Although most common side effects resolve with continued use, patients are encouraged to notify their healthcare provider if symptoms persist or worsen. Adjusting the dosage or switching formulations may provide relief.

Serious Side Effects

More severe side effects are uncommon but require immediate medical attention:

• Significant Hypotension: Excessive lowering of blood pressure may cause fainting, severe dizziness, or weakness. This risk increases when combined with other heart medications.
• Allergic or Severe Skin Reactions: Patients may experience rash, swelling, or difficulty breathing, particularly in the presence of liver impairment or drug interactions. These reactions demand urgent evaluation.
• Liver Dysfunction: Cardizem can elevate liver enzymes or, rarely, cause jaundice. Symptoms such as dark urine, fatigue, or abdominal pain should prompt evaluation for liver injury.
• Irregular Heart Rhythms: While Cardizem is used to manage arrhythmias, paradoxical worsening or the onset of new arrhythmias may occur in susceptible individuals and should be addressed immediately.

Prompt recognition of serious adverse effects enables timely intervention, which may include dose reduction, temporary discontinuation, or alternative therapy.

Cardizem interacts with a variety of medications, and these interactions may alter its plasma levels, increase the risk of side effects, or affect the efficacy of other drugs. A thorough medication review is essential before starting or adjusting Cardizem therapy.

Primary Drug Interactions

Cardizem has several clinically significant interactions:

• Beta-Blockers: Used together, these medications can intensify reductions in heart rate and blood pressure. Close monitoring is required to prevent severe bradycardia or dizziness.
• Statins (e.g., Simvastatin): Cardizem inhibits enzymes that metabolize certain statins, potentially increasing statin levels and raising the risk of muscle toxicity. Dosage adjustments are often necessary.
  • 2025 Drug Interaction Alert: Cardizem is a strong CYP3A4 inhibitor, and this interaction is especially critical with statins. If you take Simvastatin (Zocor) or Lovastatin, doses must be limited to 10–20 mg, as higher doses combined with Cardizem greatly increase the risk of rhabdomyolysis (dangerous muscle breakdown).
• Digoxin: Cardizem can elevate digoxin concentrations, increasing the risk of digoxin toxicity. Regular monitoring of digoxin levels and symptom tracking is recommended.
• Paxlovid Warning: If you are treated for COVID-19 with Paxlovid, you must consult your pharmacist. Cardizem levels can skyrocket when mixed with Paxlovid, leading to dangerously low heart rates.

Other Considerations

Additional factors can influence Cardizem’s action:

• Grapefruit Products: Grapefruit juice significantly increases Cardizem levels in the bloodstream, amplifying its pharmacologic effects and increasing the risk of side effects. Patients should avoid grapefruit while taking this medication.
• Over-the-Counter Products and Supplements: Herbal remedies and OTC medications may interfere with Cardizem’s metabolism or cardiovascular effects. Patients should discuss all supplements with their healthcare provider to prevent unintended interactions.

Maintaining open communication with healthcare providers ensures safer medication regimens and optimal therapeutic outcomes.